Article

Financial Burden of Breast Cancer Tops SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

5. Smoking Causes Worsened Functioning, Respiratory Problems in Patients With MS

Patients with multiple sclerosis who smoked cigarettes had higher rates of respiratory complications and increased sedentary lifestyle. Read more.

4. Additional Inhibitor May Enhance Efficacy of Common Therapy in Combatting Glioblastoma

Supplementing a commonly used treatment approach with an additional inhibitor could help overcome resistance in glioblastoma. Read more.

3. New Trial to Evaluate Investigational Hepatitis C Vaccine

If proven effective, GLS-6150 could be the first vaccine to protect against hepatitis C virus infection. Read more.

2. FDA Approves Riluzole Oral Suspension for Treatment of ALS

The approval of riluzole oral suspension fills a therapeutic need for patients with amyotrophic lateral sclerosis who develop swallowing impairment. Read more.

1. Out-of-Pocket Costs From Breast Cancer Treatment Have Long-Lasting Impact

Survivors of breast cancer and their families face long-term cumulative financial implications from treatment and associated costs. Read more.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards